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Abstract
We previously reported that the expression of KIAA1199 in human colorectal tumors (benign and malignant) is markedly
higher than that in the normal colonic mucosa. In this study, we investigated the functions of the protein encoded by this
gene, which are thus far unknown. Immunostaining studies were used to reveal its subcellular localization, and proteomic
and gene expression experiments were conducted to identify proteins that might interact with KIAA1199 and molecular
pathways in which it might play roles. Using colon cancer cell lines, we showed that both endogenous and ectopically
expressed KIAA1199 is secreted into the extracellular environment. In the cells, it was found mainly in the perinuclear space
(probably the ER) and cell membrane. Both cellular compartments were also over-represented in lists of proteins identified
by mass spectrometry as putative KIAA1199 interactors and/or proteins encoded by genes whose transcription was
significantly changed by KIAA1199 expression. These proteomic and transcriptomic datasets concordantly link KIAA1199 to
several genes/proteins and molecular pathways, including ER processes like protein binding, transport, and folding; and
Ca2+, G-protein, ephrin, and Wnt signaling. Immunoprecipitation experiments confirmed KIAA1199’s interaction with the
cell-membrane receptor ephrin A2 and with the ER receptor ITPR3, a key player in Ca2+ signaling. By modulating Ca2+
signaling, KIAA1199 could affect different branches of the Wnt network. Our findings suggest it may negatively regulate the
Wnt/CTNNB1 signaling, and its expression is associated with decreased cell proliferation and invasiveness.
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Introduction
The function of the protein encoded by KIAA1199 is currently
unknown, but our previous studies have documented marked
overexpression of this gene–at both the mRNA and protein levels–
in almost all colorectal tumors (benign and malignant) [1,2]. More
recently, similar upregulation has also been reported in a large
series of colorectal cancers [3] and in gastric cancers [4]. On the
basis of our findings (gene expression data, protein expression
patterns in colorectal tissues, the results of in silico analysis), we
have suggested that KIAA1199 might be a Wnt target gene. It
appears to encode a secreted membrane/cytoplasmic protein that
is structurally similar to several other eukaryotic proteins,
including transmembrane protein 2, polyductin, and fibrocystin
L, all of which are large receptor proteins with an N-terminal
signal peptide or a single transmembrane helix and short
cytoplasmic tail [1].
These findings raise interesting possibilities for the development
of a new molecular marker for detecting gastrointestinal
neoplasms. KIAA1199 mRNA has been detected in the plasma
of almost 80% of individuals with colorectal adenomas or cancers
[5]. Unfortunately, it was also identified in 30% of tumor-free
controls, so its ultimate diagnostic value remains to be seen.
Attempts have also been made to explore the prognostic
significance of KIAA1199 mRNA or protein expression levels in
colorectal [3] and gastric [4] cancers and in mesotheliomas [6],
but in most cases the study cohorts were too small to allow any
meaningful conclusions to be drawn. In the meantime, little or no
progress has been made toward identifying KIAA1199’s role(s) in
normal and neoplastic cells. The present study represents a first
step toward the filling of this gap.
Materials and Methods
Cell Lines
Human SW480 colon cancer cells from the Cancer Network
Zurich cell line repository were used for most of the experiments
conducted in this study. Their authenticity was verified by
microsatellite analysis performed in January 2012 at Microsynth
AG, Switzerland. The cells were cultured in RPMI 1640 medium
(Invitrogen) supplemented with 10% fetal calf serum (Gibco),
100 IU penicillin, and 100 mg/ml streptomycin.
Clones that constitutively express KIAA1199 were obtained by
Lipofectamine 2000 (Invitrogen)-mediated transfection of SW480
cells with the pcDNA3.2V5DEST vector containing KIAA1199
ORF (described below). The clones were selected and maintained
in medium containing G418 (0.4 mg/ml) (Gibco).
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Inducible KIAA1199 expression was achieved with a two-step
procedure. First, SW480 cells were transfected with the
pcDNA6TR vector (Invitrogen) and the tetracycline repressor-
expressing cells selected with 7 mg/ml blasticidin S (InvivoGen).
The blasticidin-resistant cells were then transfected with the pT-
Rex-DEST30-KIAA1199 construct (described below) and selected
with 0.4 mg/ml G418. The growth medium used for these cells
was supplemented with 10% Tet-system-approved fetal calf serum
(Biochrom). For induction of KIAA1199 expression, doxycycline
(Clontech) was used at concentrations of 50–200 ng/ml, which
have been shown to have no effects on transcript levels measured
with microarrays [7].
Cloning of Full-length KIAA1199
Full-length KIAA1199 was PCR-amplified from LS180 cell
cDNA with Phusion Hot-Start High Fidelity DNA Polymerase
(Finnzyme) and the following primers: forward 59-GGA TAT
GGT ACC ACA CTG CCA GGA TGG GAG CTG-39, reverse
59-GAT ATC TCG AGC TAC AAC TTC TTC TTC TTC
ACC ACA GGG ATG-39. The amplified KIAA1199 open reading
frame was then inserted into the pENTR11 vector (Invitrogen)
with the aid of KpnI/XhoI restriction enzymes, and an LR
recombination reaction (Gateway, Invitrogen) was carried out to
clone it into the constitutive expression vector pcDNA3.2V5DEST
(with or without a C-terminus V5 tag) and into the Tet-on
inducible vector pT-Rex-DEST30 (untagged and C-terminus
GFP-tagged proteins). The C-terminus was chosen for tagging
since KIAA1199 contains a signal peptide at its N-terminus.
Whole-cell Lysates and Conditioned Medium
Concentrates
Cells were trypsinized, washed with PBS, and placed in cold
single-detergent lysis buffer (1% NP-40, 350 mM NaCl, 50 mM
Tris-Cl, 1 mM EDTA, 1X Complete EDTA-free Protease
Inhibitor Cocktail [Roche], and 1 mM PMSF) for 60 minutes.
After 45 min of centrifugation (20,800 g at 4uC), the clarified
lysates were aliquoted and snap-frozen in liquid nitrogen.
When cells reached ,80% confluence, complete medium was
removed, and the cells were washed with PBS and cultured in
serum-free medium for 8 hours. The medium was then collected
and supplemented with 1 mM PMSF and 1X Complete EDTA-
free. Floating cells were spun down at 100 g for 5 minutes, and the
clarified medium was concentrated by centrifugation at 3000 g
with Amicon Ultra centricons (10 kDa NMWL).
Subcellular Fractionation
Cells were harvested by trypsinization, washed with PBS, and
centrifuged. The pellets were resuspended (,108 cells/ml) in cold
hypotonic buffer (200 mM Hepes pH 7.9, 50 mM KCl, 15 mM
MgCl2, 1 mM PMSF and 1X Complete EDTA-free, 1 mM
DTT). Cells were then transferred to a Dounce homogenizer, left
to swell on ice for 5 minutes, and lysed with a B type pestle until
microscopic examination revealed that most nuclei were trypan
blue-positive but still intact. The nuclei were then spun down
(2000 g for 10 minutes), and the supernatant (i.e., the cytoplasmic
extract) was clarified (12,000 g), aliquoted, and frozen. The nuclei
were then resuspended in half the packed nuclear volume of low-
salt buffer (20 mM Hepes pH 7.9, 25% glycerol, 1.5 mM MgCl2,
20 m M KCl, 0.2 mM EDTA, 0.5 mM PMSF, and 0.5 mM
DTT) and stirred. Half the packed nuclear volume of high-salt
buffer was then added (0.6 M KCl in low-salt buffer) drop-wise.
The suspension was stirred for 30 min and centrifuged at 20,000 g
to extract nuclear proteins. The pellet was resuspended in single-
detergent lysis buffer (described above), incubated for 30 minutes,
and centrifuged at 20,800 g. The supernatant (referred to hereafter
as the ER-nuclear membrane-chromatin fraction) was aliquoted
and snap-frozen. All steps were carried out on ice in the cold
room.
Cell-membrane Extract
Cells grown in 15-cm dishes were washed 3 times with PBS and
lysed in 1 ml/dish lysis buffer (300 mM mannitol, 20 mM Hepes-
Tris pH 7.4, 2 mM EDTA, 1 mM PMSF, 1X Complete EDTA-
free). The cell suspension was homogenized by syringing with a
25G needle, and lysis was verified under the microscope with
trypan blue staining. The lysate was centrifuged for 10 min at
100 g (4uC) to eliminate cellular debris and then ultracentrifuged
(287,660 g) at 4uC for 45 minutes. The supernatant was discarded.
The membrane pellet was homogenized by syringing with a 25G
needle and suspended in a resuspension buffer (300 mM Mannitol,
20 mM Hepes-Tris pH 7.4, 2 mM EDTA, 0.1% Triton X-100,
0.5% Na-deoxycholate, 1 mM PMSF, 1X Complete EDTA-free)
to obtain the cell membrane extract.
Antibodies
The following primary antibodies were used: rabbit polyclonal
anti-KIAA1199 (SDIX, no. 4575.00.02); mouse monoclonal anti-
V5 tag antibodies (Abcam, no. ab27671 for Western blotting and
immunohistochemistry; Invitrogen, no. R960-25 for immunopre-
cipitation); mouse monoclonal anti-TUBB (beta-tubulin) (Santa
Cruz, no. sc-5274); rabbit polyclonal anti-TFIIH (Santa Cruz, no.
sc-293); mouse monoclonal anti-CDH1 (E-cadherin) (BD Trans-
duction Laboratories, no. 610181); mouse monoclonal anti-
CTNNB1 (beta-catenin) (Dako, no. M3539); mouse monoclonal
anti-active CTNNB1 (Millipore, no. 05-665), which specifically
detects beta-catenin dephosphorylated at residues S37 and T41;
mouse monoclonal anti-ITPR3 (BD Transduction Laboratories,
no. 610312); mouse monoclonal anti-EPHA2 (Millipore, no. 05-
480); mouse monoclonal anti-NME2 (Abnova, no. H00004831-
M06); rabbit polyclonal anti-UBR5 (Bethyl Laboratories, no.
Figure 1. Expression and localization of KIAA1199. A. Western blots showing KIAA1199 protein levels in distinct subcellular compartments of
LS174T cells and in conditioned medium. CDH1 (E-cadherin), CANX (calnexin), TUBB, and TFIIH were used as cell-membrane, ER, cytoplasmic, and
nuclear markers, respectively. B. Immunocytochemical localization of KIAA1199 in LS174T (upper panel) and SW480 cells (lower panel). Gray
arrowheads: cell membrane expression; green arrowheads: perinuclear expression. Inset: negative control (immunostaining without primary
antibody). C. Constitutive and inducible expression of KIAA1199 in transfected SW480 cells. Top: SW480 clones expressing KIAA1199 constitutively.
Dest-V5, cells transfected with empty vector pcDNA3.2V5DEST; KIAA1199-V5, cells expressing KIAA1199-V5 tagged at C-terminus; KIAA1199-Cl.18,
cells expressing untagged KIAA1199. Bottom: SW480 clones expressing KIAA1199 upon doxycycline induction. TR, tetracycline-repressor-expressing
control cells; KIAA1199-Cl.13, cells expressing KIAA1199 only in the presence of doxycycline; KIAA1199-GFP, cells expressing C-terminal GFP-tagged
KIAA1199 only in the presence of doxycycline. The total cell extract of LS174T cells (endogenous KIAA1199 expressors) was used as a positive control;
TUBB was used as loading control. D. Subcellular localization of KIAA1199 in SW480 KIAA1199-V5 cells. CDH1, CANX, TUBB, and TFIIH were used as
cell-membrane, ER, cytoplasmic, and nuclear markers, respectively. E. Immunocytochemical staining of SW480 KIAA1199-V5 cells shows KIAA1199 in
the cell membrane (gray arrowheads) and perinuclear space (green arrowheads). Upper right inset: Fine focusing clearly reveals staining of the
nuclear membrane (red arrowheads). Lower right inset: Negative control (SW480 Dest-V5 immunostained with V5-tag-specific antibody).
doi:10.1371/journal.pone.0069473.g001
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A300-573A); mouse monoclonal anti-CUL1 (Invitrogen, no. 32-
2400); mouse monoclonal anti-LGALS3 (Novocastra, no. NCL-
GAL3); rabbit polyclonal anti-CANX (calnexin), a kind gift from
Dr. Ari Helenius of ETH Zurich; and rabbit polyclonal anti-MYC
(Santa Cruz, no. sc-764).
Immunoprecipitation and Mass Spectrometry
Cells were washed with cold PBS and scraped with a rubber
policeman into immunoprecipitation (IP) lysis buffer (150 mM
NaCl; 1% NP-40; 50 mM Tris-HCl, pH = 8.0, 1 mM PMSF,
1 mM Na3VO4, 1 mM NaF, 1X Complete EDTA-free). The
lysate was passed through a 25G needle 10 times, incubated on ice
for 1 hour, and cleared by 45 min of centrifugation at 20,800 g. A
10-microgram extract was pre-cleared by incubation for 2 hours
with Protein G Sepharose beads (GE Healthcare) for mouse
monoclonal antibodies or Protein A/G Agarose beads (Santa
Cruz) for rabbit polyclonal antibodies. The extract was then
incubated with 5 mg of primary antibody (overnight, 4uC) and
subsequently with Protein-G or A/G beads (1 h). The beads were
then washed 3 times with IP lysis buffer and boiled with 1X SDS-
bromophenol blue dye at 95uC. After 2 minutes of centrifugation
at 2700 g, the supernatant was collected in a new tube. The beads
(i.e., the pellet) were boiled again with 1X SDS-bromophenol blue
dye at 95uC and centrifuged at 2700 g. The supernatant thus
obtained was combined with the previous one.
Immunoprecipitated proteins were separated according to
molecular mass on NuPAGE Novex 4–12% Bis-Tris gels
(Invitrogen) and stained with RotiH-Blue Colloidal Coomassie
(Carl Roth GmbH). The gel lane was cut into 35 slices, and each
was destained. After in-gel digestion with trypsin (Promega), the
peptide-containing supernatants were purified via C18–ZipTip
pipette tips (Millipore). The tryptic peptides were separated on a
reverse-phase tip column (75 mm 680 mm) packed with silica-
based, reverse-phase C18 material (3 mm, 200 A˚, AQ, Bischoff
GmbH) using a linear gradient of 1% to 35% acetonitrile in
60 min. The eluted peptides were analyzed on an LTQ-Orbitrap
mass spectrometer or an LTQ-ICR-FT-Ultra mass spectrometer
(Thermo Fisher Scientific) in the data-dependent acquisition
mode. Mass spectrometry (MS) data were searched against the
Swissprot database (release 2011) using the Mascot search
algorithm (Matrix Science) and loaded into Scaffold (Proteome
Software) for further analysis. Protein assignments were accepted if
peptide and protein probability scores (generated by Peptide
Prophet and Protein Prophet algorithms) were $95% and $80%,
respectively [8,9].
Microarray Analysis
Using the RNeasy Mini Kit (Qiagen), we extracted total RNA
from cells in which KIAA1199 expression had been induced by
exposure to doxycycline (48 hours) and from uninduced control
cells (3 independent experiments). Methods used for quality
assessment of RNA, cDNA generation, hybridization of fragment-
ed and biotin-labeled DNA to Affymetrix GeneChip Human Exon
1.0 ST array, and data processing have been described in detail
elsewhere [10]. Gene expression data obtained with 21,980
transcript clusters were analyzed with the Partek Genomics Suite
(Partek). The original microarray data have been deposited in the
National Center for Biotechnology Information’s Gene Expression
Omnibus (GEO, http://www.ncbi.nlm.nih.gov/geo/) and are
accessible through GEO Series accession number GSE39575.
Immunofluorescence, Immunocytochemistry, and
Western Blot
For immunofluorescence experiments, cells grown on glass
cover-slips were washed with PBS, fixed at room temperature with
4% paraformaldehyde (20 minutes), permeabilized with 0.2%
Triton-X 100 (5 minutes), and blocked with 5 mg/ml BSA in PBS
(30 minutes). They were then incubated with primary antibody
(overnight, 4uC) and then with secondary antibodies (1 hour,
37uC). The cells were covered with DAPI-Vectashield mounting
medium (Vector Laboratories), and images were captured on an
epifluorescence microscope (Leica) equipped with Leica Applica-
tion Suite V3.3.0 software. Exposure settings were adjusted in each
experiment so that no fluorescence signals were observed in
negative control slides (i.e., those incubated without primary
antibodies).
Immunocytochemistry and Western blotting were performed as
previously described [10,11].
Luciferase Reporter Assay
CTNNB1 (beta-catenin)-dependent transcriptional activity was
studied in HEK293 cells transfected with the TOPflash or
FOPflash reporter vectors (Upstate Biotechnology), which contain
a multimeric consensus TCF/LEF binding site and an inactive
mutated homologue of this site, respectively. Briefly, cells were
seeded in 24-well plates (26104 cells/well), cultured for 16 hours,
and transfected in triplicate (via Lipofectamine LTX, Invitrogen)
with a mixture of 75 ng reporter vector, 20 ng pCMVbeta-Gal co-
reporter, and 50 ng pcDNA3-CTNNB1 (wild-type or constitu-
tively active CTNNB1T41A kindly provided by M.A. Buendia of
the Institut Pasteur in Paris), plus 120 ng of either mock,
KIAA1199, or TCF4-DN plasmid (this latter from Hans Clevers,
Hubrecht Institute, Utrecht, NL). Medium was replaced 8 hours
post-transfection, and luciferase activity was assayed 48 h later
Figure 2. KIAA1199 interactome and gene expression changes associated with KIAA1199 expression in SW480 cells. A. The table
shows cell lines and antibodies used in the three immunoprecipitation experiments performed to identify proteins that interact with KIAA1199. B.
Representative Western blots showing the results of the immunoprecipitation experiments summarized in the table. Input: exp.1 and 3, KIAA1199-V5
extract; exp.2, KIAA1199-Cl.18 extract. C. Silver-stained gel showing unique bands present only in the KIAA1199 immunoprecipitate (black asterisk)
following IP with antibodies against the V5 tag. (The immunoprecipitated KIAA1199 is indicated with a red asterisk.) D. Upper four strips: Western
blot showing co-immunoprecipitation of ITPR3 with anti-KIAA1199 antibody and reciprocal co-immunoprecipitation of KIAA1199 with anti-ITPR3
antibody. Lower four strips: Western blot showing co-immunoprecipitation of EPHA2 with anti-KIAA1199 antibody (arrowheads) and reciprocal co-
immunoprecipitation of KIAA1199 with anti-EPHA2 antibody. Input: KIAA1199-Cl.18 extract. The weak interactions of these two proteins with
KIAA1199 might be related to the fact that IP was performed using extracts from cells in which these two proteins were endogenously expressed
(instead of overexpressed). E. Top: Western blot showing KIAA1199 protein levels in SW480 Clone 13 total cell extracts and in conditioned medium
before and after doxycycline induction. TUBB: loading control. Bottom: Principal component analysis (PCA) of log2 KIAA1199 mRNA expression
intensity values. The plot of PCA scores for the six samples 48 h after doxycycline induction shows clear separation of replicates with (n = 3) vs.
without (n = 3) KIAA1199 expression. The first three principal components explain 72.9% of the total variance. F. Heatmap showing expression of the
490 differentially expressed genes (y axis) before and after doxycycline-induced KIAA1199 expression in three replicate experiments. (Green:
upregulated; red: downregulated in KIAA1199-expressing cells; p value ,0.025, and fold change .1.2).
doi:10.1371/journal.pone.0069473.g002
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Table 1. Gene ontologies (GO) and interactomes over-represented in the lists of putative KIAA1199 interactors and genes whose
transcript levels were affected by KIAA1199 expression.
89 putative interactors of KIAA1199 (IP/MS data)
490 genes whose expression changed upon KIAA1199 expression
(microarray data)
Enrichment Ontologies and Interactome p value Enrichment Ontologies and Interactome p value
GO cellular localization GO cellular localization
Cytoplasm Organelle
cytoplasmic part 2.93E-10 organelle part 2.18E-14
cytoplasm 3.28E-10 intracellular organelle 1.10E-13
Organelle intracellular membrane-bounded organelle 5.57E-11
pigment granule 4.02E-11 membrane-enclosed lumen 1.05E-06
membrane-enclosed lumen 2.18E-09 intracellular organelle lumen 1.21E-06
organelle lumen 4.97E-09
cytoplasmic membrane-bounded vesicle 3.72E-07 Cytoplasm
membrane-bounded organelle 4.79E-07 cytoplasmic part 2.60E-08
ER lumen 3.25E-06 cytoplasm 1.66E-06
Proteosome complex 1.08E-06
Pathway Maps Pathway Maps
CTFR (Cystic fibrosis transmembrane conductance regulator)
folding and maturation
9.61E-05 Transport
Rab-9 regulation pathway 1.13E-05
G-protein signaling Clathrin-coated vesicle cycle 8.29E-04
G protein-coupled receptors in blood coagulation 1.00E-04 Sorting endosome formation in cystic fibrosis 7.49E-02
S1PR1 signaling pathway (also S1PR2 and S1PR3) 1.95E-04 Cytoskeleton remodeling
G-protein signaling_Regulation of cAMP levels by ACM 2.13E-04 Role of Activin A in cytoskeleton remodeling 1.13E-05
Alpha-2 adrenergic receptor regulation of ion channels 2.52E-04 TGF, WNT and cytoskeletal remodeling 5.75E-05
Alpha-2 adrenergic receptor activation of ERK 7.33E-04 Role of PKA in cytoskeleton reorganisation 3.74E-04
Regulation of actin cytoskeleton by Rho GTPases 5.32E-03
Cell adhesion Cell adhesion
Chemokines and adhesion 5.03E-04 Histamine H1 receptor signaling in the interruption of cell barrier
integrity
6.58E-05
Ephrin signaling 3.24E-03 Ephrin signaling 5.25E-03
Histamine H1 receptor signaling in interruption of cell
barrier integrity
3.24E-03 Transcription
ECM remodeling 4.88E-03 Role of heterochromatin protein 1 (HP1) family in transcriptional
silencing
3.40E-04
Apoptosis and survival
Transcription Anti-apoptotic action of Gastrin 5.27E-04
Role of Akt in hypoxia induced HIF1 activation 7.26E-04 BAD phosphorylation 4.09E-03
Cell cycle
Immune response Initiation of mitosis 5.68E-04
Antigen presentation by MHC class I 8.10E-04 Role of alpha-6/beta-4 integrins in carcinoma progression 6.52E-04
CCR4-induced chemotaxis of immune cells 1.38E-03 Development
SSTR1 in regulation of cell proliferation and migration 1.01E-03
Glycolysis and gluconeogenesis 1.20E-03 Endothelin-1/EDNRA signaling 1.38E-03
FGFR signaling pathway 1.50E-03
Guanosine/hypoxanthine triphosphate metabolism 2.92E-03 TGF-beta-dependent induction of EMT via RhoA, PI3K and ILK 5.68E-03
G-protein signaling
Role of alpha-6/beta-4 integrins in carcinoma progression 3.24E-03 G-protein alpha-q signaling cascades 1.86E-03
S1PR2 receptor signaling 2.08E-03
Signal transduction
IP3 signaling 7.12E-03
Activation of PKC via G-protein coupled receptor 8.78E-03
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with the Promega Luciferase assay kit (Promega). Results for each
sample were normalized to beta-galactosidase activity (High-
sensitivity beta-galactosidase assay kit, Stratagene). For each
construct combination, the TCF/LEF-specific transactivation
was quantified by dividing the TOPflash luciferase activation by
the average FOPflash activity. Luciferase reporter assays were also
performed in SW480 Cl.18 cells.
Proliferation, Colony Formation, Transwell Invasion and
Migration Assays
Cells were seeded in duplicate in 6-well plates (5000 cells/well)
and grown under standard conditions. At each time point, cells
were trypsinized, stained with trypan blue, and counted with a
hemocytometer.
For colony formation assays, cells were seeded in triplicate in
100-mm dishes (1000, 500, and 100 cells/dish). After 11 days of
growth, the cells were fixed (10 minutes in methanol/PBS, 1:1),
washed in pure methanol (2 minutes), and stained with 20 mg/ml
of Crystal Violet Certistain (Merck). Colonies containing .50 cells
were identified by manual counts under the microscope.
For invasion assays, 8-microm transwell permeable supports
(BD Biosciences) were coated with 50 ml of 0.5 mg/ml Matrigel (BD
Biosciences), allowed to dry for 3 hours at room temperature, and
rehydrated with 300 ml RPMI medium for 1 hour at 37uC. The
upper chamber was seeded (in triplicate) with 200,000 cells; the
lower chamber was filled with medium containing 500 ml of 20%
fetal calf serum (as a chemoattractant). Forty-eight hours later, the
insert was cleaned thoroughly with a cotton swab to remove any
cells that had not passed through the membrane. It was then
placed in 2% formaldehyde (freshly prepared in PBS) to fix the
cells (10 minutes) and washed 3 times with PBS. DNA was stained
with DAPI (10 minutes), and 20 randomly selected fields were
imaged with an Olympus IX81 microscope equipped with Cell‘R
software (Olympus, Japan). Stained nuclei were counted with the
Count tool of the Adobe Photoshop program (Adobe).
Cell migration was comparatively assessed in KIAA1199
expressing clones and SW480 Dest (controls) using the in vitro
scratch test, as described elsewhere [12].
Statistical Analysis
For microarray experiments, p values were generated with a
paired, two-tailed t test performed in the Partek Genomics Suite
and the results subjected to Benjamini-Hochberg correction. To
select genes whose mRNA levels changed upon KIAA1199
expression, we used an unadjusted p value threshold of 0.025,
the equivalent of a Benjamini-Hochberg adjusted p value of 0.55.
For other experiments reported in this study, two-tailed p values
were calculated with paired or unpaired t tests performed with the
GraphPad Prism 5.0 statistical software package.
Table 1. Cont.
89 putative interactors of KIAA1199 (IP/MS data)
490 genes whose expression changed upon KIAA1199 expression
(microarray data)
Metabolic Networks Metabolic Networks
Phosphatidylcholine pathway 2.78E-03 Phosphatidylcholine pathway 1.03E-06
Phosphatidylinositol-3,4-diphosphate pathway 2.59E-04
GO Processes GO Processes
Nucleobase-containing small molecule metabolic process 2.21E-10 Protein transport 9.77E-10
ER processes Establishment of protein localization 1.14E-09
ER unfolded protein response 1.30E-09 Nitrogen compound metabolic process 3.33E-09
Response to ER stress 4.95E-09
ER-nucleus signaling pathway 4.95E-09
GO molecular functions GO molecular functions
Protein binding 1.00E-14 Protein binding 6.00E-10
Nucleotide binding 2.63E-07
Transcription factors Transcription factors
SP1 1.12E-10 HNF4-alpha 7.04E-08
MYC 2.27E-10 MYC 2.66E-06
HNF4-alpha 3.64E-06
ATF-2/c-Jun 8.77E-06
Significant interactions within set Significant interactions within set
CTNND1/ITGB4 or TLN1 RPL4/CANX or NMP1
HSP90B1/LRP1 or HYOU1 PXN/LIMK1
ITGB4/ITGA6 ROCK1/LIMK1
LGALS3/CTSD or ITGB4
LRP1/CTSD or CANX
TARDBP/H1FX
TLN1/LRP1 or ITGA6
ITGA6/CANX
doi:10.1371/journal.pone.0069473.t001
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Results
Figure S1A shows KIAA1199 mRNA expression data from our
previous study on benign and malignant colorectal tumor tissues,
normal colorectal mucosal samples, and 8 colon cancer cell lines
[1]. The widely variable expression levels observed in these cell
lines were also seen in Western blot experiments in the present
study (Figure S1B). They probably reflect epigenetic changes at the
KIAA1199 promoter, as recently described in human breast cancer
cells [13].
The LS174T cell line, which displayed the highest expression at
both the mRNA and protein levels, was used to investigate the
subcellular localization of endogenous KIAA1199 protein. Col-
lectively, our Western blot (Figure 1A) and immunocytochemistry
data (Figure 1B) indicated that the KIAA1199 in these cells is
found mainly in the perinuclear space (presumably the ER,
including the outer nuclear membrane and ER tubules) and cell
membrane–a pattern similar to that found in normal colorectal
epithelial cells [1]. The protein also appeared to be abundantly
secreted (Figure 1A). Treatment of LS174T protein extracts with
Peptide N-glycosidase F (PNGaseF), which cleaves asparagine-
linked (N-linked) oligosaccharides from glycoproteins, increased
KIAA1199 mobility in Western blotting (Figure S2A).
Restoration of KIAA1199 expression was investigated in
SW480 cells, where KIAA1199 expression is minimal-absent
(Figure 1B and Figure S1). We established SW480 clones that
expressed tagged (C-terminal V5 or GFP) or untagged forms of
KIAA1199, constitutively (KIAA1199-V5 and KIAA1199-Cl.18)
or upon doxycycline induction (KIAA1199-Cl.13 and KIAA1199-
GFP) (Figure 1C). The subcellular KIAA1199 distribution patterns
in all these clones were virtually identical to that of endogenous
KIAA1199 in LS174T cells (see example in Figures 1D and 1E),
and all secreted the exogenously expressed protein (tagged and
untagged forms) into the conditioned media (Figure 1D).
The KIAA1199-V5 and KIAA1199-Cl.18 clones, which
displayed relatively high constitutive expression of KIAA1199
(Figure 1C), were used in IP/MS experiments designed to identify
proteins that might interact with KIAA1199. Figure 2A to 2C
show the cells and antibodies used in each of the 3 independent IP
experiments and an example of the silver staining band pattern of
the KIAA1199 immunoprecipitate. Eighty-nine proteins (Table
S1) were identified as putative KIAA1199 interactors on the basis
of MS analysis of co-immunoprecipitates. All met the following
criteria in at least 2 of the 3 experiments: 1) their peptides were
present in the KIAA1199 immunoprecipitates and absent in
control immunoprecipitates described in Figure 2A; or 2) their
presence in the KIAA1199 immunoprecipitates was observed at
least 4 times more frequently than in the control immunoprecip-
itates. Validation IP experiments were performed for several of
these proteins (CANX, CUL1, EPHA2, ITPR3, LGALS3, NME2,
and UBR5; see antibodies used in Material and Methods). ITPR3
and EPHA2 emerged as bona fide KIAA1199 interactors (Figure 2D
and Figure S3). IP is often performed with extracts from cells in
which the proteins of interest are overexpressed. The extracts used
in our experiments contain only endogenously expressed ITPR3
and EPHA2, and this may partly account for the relatively weak
interaction between these proteins and KIAA1199.
We also investigated gene expression changes 48 h after
doxycycline-mediated induction of KIAA1199 expression in
KIAA1199-Cl.13 cells. Use of this isogenic cellular system allowed
prompt detection of changes that occurred shortly after
KIAA1199 expression was switched on. (The assay time point
was chosen on the basis of the Western blot data shown in
Figure 2E). In principal component analysis, KIAA1199-express-
ing cells were clearly distinguished from the uninduced cells
(Figure 2E, three independent experiments), and expression of the
protein was associated with significant changes in the transcript-
level expression of 490 genes (Figure 2F, Table S2). Fold changes
were generally low, pointing to a moderate effect of KIAA1199
expression on the transcriptome of these cells. However, as
reported in Material and Methods, the genes listed in Table S2 were
selected using a low level of stringency. This approach was
associated with a high false discovery rate, but it increased our
chance of selecting genes that were also among the putative
KIAA1199 interactors identified in our MS experiments. In fact,
EPHA2 and ITPR3 were included in both lists although their
Figure 3. KIAA1199 exerts negative feedback on canonical Wnt
signaling. A. Ectopic KIAA1199 expression in HEK293 cells inhibits the
transcriptional activity elicited by wild-type CTNNB1 or by a constitu-
tively active form of the protein, CTNNB1-T41A. Cells were transiently
transfected with either a TOPflash or a FOPflash reporter vector,
together with an empty vector or an expression vector for KIAA1199 or
TCF4-DN. TOP/FOP ratios are the mean6 SEM of triplicate experiments.
B. Total and active CTNNB1 levels in SW480 cells expressing KIAA1199
(V5) and in empty vector-transfected (Dest) controls. The table shows
fold changes (vs. controls) in the expression of both CTNNB1 forms
induced by KIAA1199 expression based on quantification of band
intensity relative to that of CDH1 or TUBB in the same lane. TUBB was
used as loading control for cytoplasmic and nuclear fractions since it
was detectable in these fractions of the SW480-V5 and Dest cell extracts
under the same extraction conditions. Furthermore, TUBB has been
reported to shuttle to the nucleus ([50] and references herein).
doi:10.1371/journal.pone.0069473.g003
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mRNA and protein levels were only modestly changed upon
KIAA1199 expression (Figure S4). The two lists were then
interrogated with GeneGO MetaCore software (Thomson Reu-
ters) to identify any gene ontology categories or interactomes that
might be over-represented therein (Table 1). The results of these
analyses are discussed extensively below (see Discussion).
We previously showed that KIAA1199 expression is reduced by
induction of a truncated, dominant-negative form of TCF4 in
LS174T cells (Figure S2B), suggesting that it might be a novel Wnt
signaling target [1]. We now have evidence suggesting that
KIAA1199 expression exerts negative feedback on this signaling.
TOP/FOPflash reporter assays were used to assess the impact of
KIAA1199 expression on transcriptional activity elicited by wild-
type CTNNB1 or by CTNNB1-T41A, a constitutively active form
of the protein with a threonine-for-alanine substitution resulting in
a non-phosphorylatable protein at residue 41. In HEK293 cells,
which are KIAA1199-nonexpressors (data not shown), ectopic
KIAA1199 expression clearly inhibited the transcription evoked
by both forms of CTNNB1 (Figure 3A) and significantly reduced
the expression of wild-type and constitutively active CTNNB1
(Figure S5A). These effects were less evident in SW480, which are
characterized by particularly strong TCF transactivation [14].
Owing in all probability to insufficiently high transfection
efficiency, CTNNB1-driven transactivation of the TCF-responsive
promoter in SW480 KIAA1199 Cl.18 cells was only modestly (but
nonetheless significantly) decreased relative to that observed in
SW480 Dest controls (Figure S5B). Consistently, ectopic
KIAA1199 expression produced only limited decreases in active
CTNNB1 protein levels (i.e., those detected by antibodies
recognizing the protein dephosphorylated at residues S37 and
T41) and had even fewer effects on total CTNNB1 expression
(Figure 3B). This downregulation–in both the nuclear and
cytoplasmic compartments–was more evident in immunocyto-
chemical (Figure 4A) and immunofluorescence (Figure 4B) studies
performed on KIAA1199-V5 and KIAA1199-GFP clones,
respectively. It appears to be a post-transcriptional effect since
our microarray experiments revealed no decrease in CTNNB1
mRNA levels. (Correlation between KIAA1199 and CTNNB1
protein expression patterns in neoplastic tissues could not be
assessed since all tumors invariably showed overexpression of
KIAA1199 [1].).
Restoration of KIAA1199 expression also altered SW480 cell
morphology (Figure 5A). Control SW480 Dest cells, like the
parental SW480 line [15,16], tended to be round, and confluent
cultures were characterized by clusters of piled-up cells. In
contrast, KIAA1199-V5-expressing cells were flatter with a more
epithelial-like aspect. These changes were consistent with the lower
proliferation rates (Figure 5B) and reduced cloning efficiency
(Figure 5C) observed in KIAA1199-V5 cells. The KIAA1199-
expressing cells also displayed decreased in vitro invasiveness
(Figure 5D), but their directional migration in the in vitro scratch
test was not significantly different from that of controls (data not
shown). These cellular phenotypes were confirmed in Clone 18,
which also expressed KIAA1199 constitutively, but they could not
be consistently reproduced by doxycycline-induced KIAA1199
expression in Clone 13.
Discussion
Using colon cancer cell lines with endogenously or ectopically
expressed KIAA1199, we carried out subcellular localization, gene
expression, and proteomic studies aimed at delineating the
functions of this currently uncharacterized protein. Our findings
show that KIAA1199 is a glycosylated protein located predom-
inantly in the perinuclear space (probably the ER, including both
the outer nuclear membrane and ER tubules) and plasma
membrane. It is also secreted into the extracellular environment
(and additional studies are being planned to explore its functions in
that milieu). Collectively, these features are suggestive of a protein
with functions in distinct membranous cell compartments and they
are completely in line with the results of our 2-pronged high-
throughput analysis. The lists we compiled of genes encoding
putative KIAA1199 interactors and genes whose transcription is
significantly up- or downregulated by KIAA1199 expression
(Tables S1 and S2) both point to organelles and/or cytoplasm as
KIAA1199’s probable location within the cell (Table 1). Indeed,
the 11 genes on both lists all encode proteins known to be localized
in these compartments (ACADVL, CANX, EIF3E, EPHA2,
FASN, HPRT1, ITPR3, MFGE8, PSMB2, TAGLN2, and TKT–
12.4% of the putative interactor proteins).
Both lists also exhibit strong enrichment for components of cell
membrane-associated pathways (Table 1). The cell-membrane
receptor ephrin A2 (EPHA2), for example, interacts with
KIAA1199, and EPHA2 transcript and protein levels increased
slightly upon expression of KIAA1199. The EPHA2 receptor plays
key roles in cell adhesion and migration, cytoskeletal organization,
mitogenic and survival signaling (e.g., MAP/ERK and PI3K
pathways), angiogenesis, and tumor neovascularization [17], and it
has been extensively investigated as a therapeutic target in pre-
clinical cancer models [18]. EPHA2 and ephrins can produce
opposite effects via bidirectional and unconventional signaling
modalities, which–to further complicate matters–vary considerably
from one cell type to another [19]. This makes it very difficult at
this stage of our research to speculate on the outcome of the
KIAA1199/EPHA2 interaction in our SW480 clones, in partic-
ular, whether it is in any way responsible for the phenotype of
KIAA1199-expressing cells shown in Figure 5. Another membrane
receptor, the ITGA6/ITGB4 (alpha-6/beta-4) integrin complex, also
appeared in both our lists. Its abnormal function has been
implicated in the progression of carcinomas (Table 1), including
those of the colon [20]. When bound by extracellular matrix
molecules like laminin, ITGA6/ITGB4 functions with growth
factor receptors to bring about hemidesmosomal and cytoskeletal
rearrangements and trigger various forms of intracellular signaling
(e.g., MAP/ERK and PI3K) that lead to gene expression changes
[20–22]. A very recent study indicates that KIAA1199 is involved
in hyaluronan catabolism in the dermis of the skin and arthritic
synovium [23]. Its effects, which are upregulated by histamine and
down-regulated by TGFb1, are mediated by the cell membrane-
associated, clathrin-coated pit pathway. Interestingly, combined
analysis of our microarray and proteomic data also pointed to the
clathrin-coated vesicle cycle, Histamine H1 receptor signaling, and TGFb
dependent mechanisms (Table 1). Finally, PLXNA2, a membrane
receptor involved in cell adhesion and motility [24], was found to
Figure 4. Ectopic expression of KIAA1199 decreases cytoplasmic and nuclear levels of CTNNB1. A. Immunocytochemical staining for
total and active CTNNB1 in empty vector-transfected SW480 cells (Dest-V5) and SW480 cells expressing KIAA1199-V5 constitutively. The latter cells,
presented decreased CTNNB1 levels in the nucleus and cytoplasm. B. Similar results were observed in SW480 KIAA1199-GFP cells
(immunofluorescence experiments). Although only a fraction of these cells exhibited substantial KIAA1199-GFP expression upon doxycycline
induction, the vast majority displayed CTNNB1 depletion (total and active forms) in both the nucleus and cytoplasm, which is probably a paracrine
effect of secreted KIAA1199.
doi:10.1371/journal.pone.0069473.g004
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Figure 5. Effect of ectopic constitutive KIAA1199 expression on SW480 cell morphology, proliferation, and invasiveness. SW480
KIAA1199-V5 cells were compared with SW480 Dest-V5 cells (empty vector controls). Each cell phenotype shown in this figure is based on the results
of at least three independent experiments. Mean values6 SEM are reported. A. Morphology of control (left) and KIAA1199-V5-expressing cells (right)
at low (top) and high (bottom) confluence. Control SW480 Dest cells, like the parental SW480 line [15,16], tended to be round (arrow), and confluent
cultures were characterized by clusters of piled-up cells (ellipse). In contrast, KIAA1199-V5-expressing cells were flatter with a more epithelial-like
aspect (arrowhead). Compared with controls, KIAA1199-V5-expressing cells also displayed: B. diminished proliferation rates; C. reduced colony
formation; and D. a decrease in invasiveness of ,45%.
doi:10.1371/journal.pone.0069473.g005
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interact with KIAA1199 in a study based on yeast two-hybrid
screens [25]. We cannot confirm or exclude such interaction
because on the basis of our microarray screen, PLXNA2 does not
appear to be expressed in SW480 cells.
Links between KIAA1199 and branches of the G-protein signaling
pathway also emerged from our transcriptional and proteomic
data sets. The list of putative KIAA1199 interactors was enriched
for G proteins that mediate the effects of the S1P (sphingosine-1-
phosphate)/S1P receptor (S1PR1, 2 and 3) axes (Table 1). In
concert with growth factor receptors, S1PRs regulate tumor cell
growth, survival, motility and metastasis, as well as vascular
permeability and angiogenesis [26,27]. Interestingly, signaling
through S1PR2 also modulates vascularization of the cochlea,
where murine KIAA1199 mRNA is highly expressed [28]. In fact,
S1pr22/2 mice are deaf [29,30], and missense variants in the
KIAA1199 gene are associated with nonsyndromic hearing loss in
humans [28].
The lists of GO pathway maps, processes, and molecular
functions point strongly toward the ER and functions linked to this
organelle, like protein binding, folding, transport, and localization
(Table 1). As the major reservoir of intracellular Ca2+ in epithelial
cells, the ER also plays an essential role in the Ca2+ signaling that
regulates many cell functions [31]. Inositol 1,4,5-triphosphate
receptors (ITPRs), ligand-gated ion channels that are activated by
cytosolic Ca2+ and IP3, are localized in intracellular membranes,
where they mediate the mobilization of intracellular Ca2+ stores.
ITPR3 was among the putative KIAA1199 interactors we
identified and validated, and expression of ITPR3 mRNA was
moderately upregulated upon KIAA1199 expression in micro-
array experiments. These channels are found on ER membranes
of most animal cells, and they are key players in Ca2+ signaling
[32,33].
The strong representation of Ca2+ signaling in our data sets also
points to a potential role of KIAA1199 in the Wnt network (see
Table 1). For example, intracellular Ca2+ release upon ligand
binding is mediated by trimeric G-proteins, which are involved in all
three components of the Wnt network, i.e., the canonical Wnt/
CTNNB1(beta-catenin) pathway, the Wnt/calcium pathway, and
the Wnt/Jun N-terminal kinase pathway [34–36]. Activation of
PKCs via G-protein-coupled receptors requires diacylglycerol and Ca2+,
and it plays roles in different Wnt pathways [36–40]. Canonical
Wnt signaling is inhibited by G protein/Ca2+-mediated nuclear
export and calpain-mediated degradation of CTNNB1 [41] and
by Wnt/CTNNB1-antagonizing NKD proteins [42–44]. Accord-
ingly, we found that KIAA1199 expression increased NKD1 (p
= 0.04) and CAPN1 (calpain large subunit; p = 0.03) transcription,
and the calpain small subunit (CAPNS1) appears to interact with
KIAA1199 (Table S1). These findings are consistent with the
results of our GO analysis, which revealed enrichment of MYC-
associated transcription regulation, although KIAA1199 expression had
no significant effect on the expression of MYC mRNA or protein
(data not shown). Both lists (Table 1) also displayed enrichment for
Wnt effects on cytoskeletal remodeling and for transcriptional regulation by
HNF4A, another key regulator of intestinal epithelium homeostasis
that modulates Wnt/CTNNB1 signaling [45].
It is premature to speculate on how KIAA1199’s possible
functions in the complex Wnt network might affect canonical
Wnt/CTNNB1 signaling in colorectal tissues. However, our data
suggest that KIAA1199 is a Wnt signaling target (Figure S2B; see
also Ref. [1]) and that its expression can downregulate Wnt
signaling via a negative feedback mechanism. CTNNB1-depen-
dent transcriptional activity was significantly (albeit incompletely)
inhibited by ectopic expression of KIAA1199 in HEK293 cells,
and in SW480 clones nuclear and cytoplasmic levels of CTNNB1
dropped considerably when KIAA1199 expression (untagged as
well as V5- or GFP-tagged forms) was restored. These findings are
fully consistent with one another despite the markedly different
subcellular localizations of CTNNB1 in these two cell lines. In
HEK293 cells, CTNNB1 immunostaining typically exhibits a cell-
border, CDH1-associated pattern, whereas SW480 cells, which
harbor a truncated APC (adenomatous polyposis coli) protein,
generally have inordinately high CTNNB1 levels in the cytoplasm
and nucleus [46]. Restoration of APC expression in SW480 cells is
followed by translocation of CTNNB1 and CDH1 to the cell
membrane and diminished Wnt signaling [47]. The drop in
cytoplasmic and nuclear CTNNB1 levels we observed in SW480
cells following KIAA1199 expression was not associated with this
type of translocation. Furthermore, the restored expression had no
detectable impact on MYC mRNA or protein levels in these cells.
It remains to be seen whether KIAA1199 modulates CTNNB1
expression patterns in SW480 cells via non-canonical Wnt
signaling pathways.
Regardless of its underlying mechanisms, this modulation could
have important effects on gene transcription and phenotypic
features like cell proliferation and adhesion. Upregulated
KIAA1199 expression during colorectal transformation [1] could
restrain cell growth by negatively regulating Wnt signaling.
Indeed, upregulated KIAA1199 transcription in human renal cell
carcinoma cells [48] and cultured myotubes [49] is associated with
cellular or gene-expression features of cell mortality/senescence or
apoptosis, and these findings are consistent with the diminished
proliferation, cloning efficiency, and invasiveness we observed in
SW480 clones that constitutively express KIAA1199. Additional
work is needed, however, to clarify the link between the protein’s
effects on cell behavior and its impact on Wnt signaling.
Our findings contradict recent findings by Birkenkamp-Dem-
troder et al. that shRNA-mediated repression of KIAA1199
expression attenuates Wnt signaling in parental SW480 cells [3].
Endogeneous KIAA1199 expression is negligible or absent in
molecularly authenticated SW480 cells, as clearly shown by our
own data (Figure 1, Figure S1) and also those of Birkenkamp-
Demtroder et al. (Supplementary Figure 2a, lanes 2 and 3). It is
therefore difficult to see how significant knock-down of KIAA1199
expression can be achieved in this cell line. Unfortunately, the
authors have not documented their shRNA-mediated repression
by Western blotting. (We used stable shRNA transfection in an
attempt to knock down endogenous KIAA1199 expression in
LS174T cells, which express high endogenous levels of
KIAA1199, but the clones produced were not viable.) When
Birkenkamp-Demtroder et al. transfected SW480 cells with V5-
His-tagged-KIAA1199, their findings seem much more consistent
with our own: their microarray analysis showed that this
exogenous expression was associated with significant changes in
the expression of genes involved in the ephrin and Wnt signaling
pathways. More in-depth comparative analysis of microarray
findings from our study and theirs is not currently possible since
the raw data from the latter study do not appear to have been
deposited in a publicly available database (or there is no
information to this effect in their article).
In conclusion, although further work is obviously needed, our
data on the restoration of KIAA1199 expression provide useful
guidance for future work on this membranous and secreted
protein, which appears to be involved in the modulation of ER
processes and in Ca2+, G-protein, ephrin, and Wnt signaling.
Future studies based on other cell models are already being
planned to clarify the impact of KIAA1199 on Wnt signaling.
Later, the tumorigenicity and metastatic potential of KIAA1199-
expressing SW480 cells might be compared with those of
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non- KIAA1199-expressing control cells in murine xenograft
models. Furthermore, because KIAA1199 is a secreted protein, it
will be interesting to see if full-length or cleaved forms of the
protein can be detected in the blood of the tumor-bearing mice.
These experiments could furnish proof of principle for developing
KIAA1199 as a secreted biomarker for colorectal neoplasia.
Supporting Information
Figure S1 Expression of KIAA1199 mRNA and protein in
colorectal tissues and cell lines. A. Expression values for
KIAA1199 mRNA in 32 samples of normal colorectal mucosa, 32
colorectal adenomas, 25 colorectal cancers, and 8 colorectal
cancer cell lines (Affymetrix U133Plus2.0 gene expression data
from a previous study of ours [1]) B. Western blots showing
KIAA1199 protein expression in the 8 cell lines. Beta-tubulin
(TUBB) was used as loading control.
(TIF)
Figure S2 KIAA1199 is an N-linked glycoprotein and a
putative target of Wnt signaling. A. Western blot comparing
KIAA1199 mobility in whole cell extracts from LS174T cells that
were untreated, denatured by boiling at 100uC followed by
PNGaseF treatment, or treated with PNGaseF alone. Mobility in
the latter two extracts was similarly increased (vs. that observed in
the untreated extract), suggesting that N-linked sugar residues on
KIAA1199 were accessible to the enzyme even without prior
denaturation. TUBB was used as loading control. B. Western blot:
Doxycycline induction of dominant negative TCF4 (TCF4-DN)
expression reduces expression of KIAA1199 and MYC proteins in
LS174T colon cancer cell clone 8 (LS174T/L8; kindly provided
by Dr. Hans Clevers, Hubrecht Institute, Utrecht, The Nether-
lands). ERCC3 (TFIIH p89) was used as loading control.
(TIF)
Figure S3 Partial colocalization of KIAA1199 and ITPR3
in the ER. In general, the anti-KIAA1199 antibodies performed
poorly in immunofluorescence experiments. However, a clear
perinuclear staining in SW480 KIAA1199-Cl.18 cells strongly
pointed to a localization of this protein in the ER. A similar
staining pattern was detected with antibodies against ITPR3,
which is a well-known ER protein. At this cellular localization,
partial overlap of KIAA1199 and ITPR3 staining was detectable
in merged images, supporting the IP findings shown in Figure 2D.
(TIF)
Figure S4 mRNA and protein expression levels of
EPHA2 and ITPR3 in SW480 cell clones with or without
KIAA1199. In triplicate microarray experiments, both EPHA2
and ITPR3 mRNA levels were found to be upregulated upon
expression of KIAA1199 (panel A), but in qRT-PCR and Western
blotting experiments appreciable increases were seen only in the
expression of EPHA2 mRNA (panel B) and protein (panel C).
(TIF)
Figure S5 (A) Ectopic KIAA1199 expression downregu-
lates CTNNB1 expression in HEK293 cells. Cells were
trasfected with an empty vector, Myc-tagged wild-type
(CTNNB1wt) or Myc-tagged constitutively active beta-catenin
(CTNNB1T41A), with (lanes 4–6) or without (lanes 1–3)
KIAA1199. Western blotting performed 48 h after transfection
revealed significant decreases in KIAA1199-transfected cells in the
expression of both wild-type CTNNB1 (lane 5 vs. lane 2) and
active CTNNB1 (lane 6 vs. lane 3). (B) Ectopic KIAA1199
expression in SW480 colon carcinoma cells produces
only moderate reductions in CTNNB1-driven transacti-
vation of TCF-responsive promoter. Left: SW480 Dest and
SW480 KIAA1199 Cl.18 cells were transfected with either
TOPflash or FOPflash reporters, and relative luciferase (RLU)
activity was assayed 36 hours later. Right: TOP/FOP ratio reflects
TCF-specific activation. Data represent the means 6 SD of
experiments performed in quadruplicate.
(TIF)
Table S1 List of putative KIAA1199 interactors identi-
fied by MS after immunoprecipitation. Molecular weight,
cellular localization, functions, and number of unique peptide hits
obtained on MS for each putative interactor is reported.
(PDF)
Table S2 Genes whose expression significantly changed
(p value ,0.025, fold change $1.2) upon doxycycline-
induced expression of KIAA1199 in SW480 Clone 13.
(PDF)
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